Sarah Roden

About the Author Sarah Roden

Sarah writes about stock market news for TipRanks. She graduated as member of Phi Beta Kappa from the University of Richmond in Richmond, Virginia.

Wells Fargo Analyst Raises Price Target on Lululemon Athletica inc. (LULU) Following Meeting with Management

Wells Fargo analyst Ike Boruchow weighed in on athletic retailer Lululemon Athletica inc. (NASDAQ:LULU), reiterating an Outperform rating and raising his price target …

Analysts Chime In on Tesla Motors Inc (TSLA), Netflix, Inc. (NFLX) as Both Seen Better Days

While Tesla Motors Inc (NASDAQ:TSLA) and Netflix, Inc. (NASDAQ:NFLX) are often in the headlines, both are learning what it is like to be …

Analysts Shine Light on Two Volatile Healthcare Stocks: TESARO Inc (TSRO) and Marinus Pharmaceuticals Inc (MRNS)

TESARO Inc (NASDAQ:TSRO) and Marinus Pharmaceuticals Inc (NASDAQ:MRNS) both made headlines this week as the biotech companies released data on pipeline drugs. While …

Phillipe Laffont’s Latest Investment Moves: Valeant Pharmaceuticals Intl Inc (VRX) and Facebook Inc (FB)

Phillipe Laffont is the driving force behind Coatue Management LLC; a hedge fund that is heavily invested in the technology sector. In the …

Biotech Beat: All Eyes On Relypsa Inc (RLYP) And EXACT Sciences Corporation (EXAS)

Both Relypsa Inc (NASDAQ:RLYP) and EXACT Sciences Corporation (NASDAQ:EXAS) received good news about their flagship products this week. Relypsa announced May prescription data …

Analysts Lay Out The Case For Two Biotechs: Galena Biopharma Inc (GALE) and Marinus Pharmaceuticals Inc (MRNS)

Amid drug trials and pipeline updates, analysts remain bullish on both Galena Biopharma Inc (NASDAQ:GALE) and Marinus Pharmaceuticals Inc (NASDAQ:MRNS). Analysts dive into …

Healthcare Analysts Weigh In on Gilead Sciences, Inc. (GILD) and Incyte Corporation (INCY) Following Management Meetings

Analysts were able to meet with management from Gilead Sciences, Inc. (NASDAQ:GILD) and Incyte Corporation (NASDAQ:INCY) to gain insight into both companies’ future plans.

Bill Ackman’s Increasing Stake in Valeant Pharmaceuticals Intl Inc (VRX)

Bill Ackman is the both the founder and CEO of the hedge fund Pershing Square Capital Management. Many consider Ackman to be a …

Stock Giants in the Limelight: Apple Inc. (AAPL) and Tesla Motors Inc (TSLA)

Technology enthusiasts have a lot to look forward to this week as smartphone giant Apple Inc. (NASDAQ:AAPL) hosts its annual Worldwide Developers Conference and …

BMO Chimes In on Healthcare Giants: Valeant Pharmaceuticals Intl Inc (VRX), Celgene Corporation (CELG), Incyte Corporation (INCY)

Analysts from sell-side firm BMO Capital weigh in on three healthcare giants. While one remains on the sidelines of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) following …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts